Skip to content

Investigating the effect of gargling normal saline and tinctured solution of sage and marshmallow plants on the incidence of sore throat, cough, hoarseness and severity of sore throat after endotracheal intubation in patients under general anesthesia.

A comparative study of the effect of gargling with normal saline and gargling with a tincture of sage and Alcea plants on the incidence of sore throat, cough and hoarseness and the severity of sore throat after endotracheal intubation in patients under general anesthesia.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230627058595N1
Enrollment
114
Registered
2023-07-31
Start date
2023-08-06
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Occurrence of sore throat, cough, hoarseness and throat severity.

Interventions

Intervention 1: The first intervention group: In the first intervention group, gargling 15-20 drops of normal saline will be administered to the patients 2 hours before the start of surgery and immedi

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • Patients under general anesthesia with intratracheal intubation • Not having a history of allergy to herbal medicine (especially the components of sage and Alcea plants or other plants from the same family) • Patients with physical condition 1 and 2 (PS or ASA) (either do not have an underlying disease or have a controlled underlying disease.) • Absence of underlying diseases of the oral cavity • Absence of specific diseases related to sore throat, such as viral and bacterial diseases. • Not taking certain drugs, especially NSAIDs, narcotics, benzodiazepines, and neuropsychiatric drugs • Age between 18 and 65 years (5) • Patients who do not have any doubts about difficult intubation during clinical examination. • Abdominal surgery that does not last more than two hours. (14) • Patients do not suffer from chronic cough and allergies

Exclusion criteria

Exclusion criteria: • The inability of the patient to continue to cooperate for any reason, such as a decrease in the level of consciousness, the death of the patient, etc.• Lack of complete access to the patient• Changing the anesthesia method during surgery for any reason• Performing intubation and laryngoscopy more than once for the patient• Length of laryngoscopy for intubation more than 30 seconds• Patients who have difficult general anesthesia and intubation process.• If the duration of surgery lasts more than 2 hours.• If NGT is used for the patient.• People who use a tracheal tube other than size 5/7 for women and 8 for men.• The patient's unwillingness to continue treatment and cooperation

Design outcomes

Primary

MeasureTime frame
Sore throat severity score based on VAS scale. Timepoint: before discharge from recovery and 6 hours later in the respective inpatient department. Method of measurement: Visual Analogue Scale.;Percentage of people with sore throat. Timepoint: before discharge from recovery and 6 hours later in the respective inpatient department. Method of measurement: Assessment of the incidence of sore throat from the patient's own statements and observation and recording by a trained assistant of the researcher in the checklist.;Cough incidence score in the scoring system designed by Harding and McVeigh. Timepoint: before discharge from recovery and 6 hours later in the respective inpatient department. Method of measurement: Harding and McVay scoring system.;Hoarseness occurrence score in the scoring system designed by Harding and McVey. Timepoint: before discharge from recovery and 6 hours later in the respective inpatient department. Method of measurement: Harding and McVay scoring system.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Shahnazari

Esfahan University of Medical Sciences

fati.shahnazari373@gmail.com+98 31 3792 7630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026